Introduction

Cavernous malformations (CMs), sometimes referred to as cavernomas or cerebral cavernous malformations (CCMs), are clusters of abnormally formed blood vessels in the brain or spinal cord.¹ Unlike other vascular malformations, CMs are low-pressure lesions made up of dilated capillary-like channels that lack intervening brain tissue.^1,2 Often silent, they can occasionally trigger symptoms like seizures, headaches, neurological deficits or haemorrhages.²

The road to diagnosing these elusive formations has been long. Eventually, with advances in imaging technology, it has become more accessible. Understanding which imaging modalities are best for detection, monitoring, and treatment planning is vital, not just for neurologists and radiologists, but for patient outcomes.¹ 

In this article, we explore the primary imaging techniques used to detect and analyse cavernous malformations, their strengths and limitations, and how they guide clinical decision-making.

Cavernous malformations

Before understanding imaging, it’s helpful to understand what CMs are and why accurate diagnosis matters. These vascular anomalies consist of tightly packed, thin-walled blood vessels that sometimes resemble a raspberry.³ They can be sporadic or inherited (familial), and are often dormant until they cause a problem.

CMs don’t usually appear on standard angiograms because they lack large feeding arteries or draining veins.³ This invisibility makes traditional vascular imaging ineffective, which is why the choice of technique is important. 

The following are some of the imaging options available:

1. Magnetic Resonance Imaging (MRI)
2. Computed Tomography (CT)
3. Digital Subtraction Angiography (DSA)
4. Functional MRI (fMRI) and other functional imaging 

Magnetic resonance imaging (MRI)

When it comes to diagnosing cavernous malformations, MRI is the gold standard.⁶ MRIs can detect tiny differences in tissue contrast, and they can expose even small, asymptomatic CMs.

• T2-weighted MRI: these images often reveal a “popcorn-like” lesion with a dark rim, a common appearance due to hemosiderin (a blood breakdown product)⁴
• Gradient Echo (GRE) and Susceptibility-Weighted Imaging (SWI): these advanced sequences enhance the detection of blood products. SWI, in particular, is highly sensitive to the magnetic effects of iron, making it good at identifying both symptomatic and silent lesions⁵
• Fluid-Attenuated Inversion Recovery (FLAIR): useful for detecting associated oedema (fluid build-up) or gliosis (when certain cells in the brain grow in size and form scar tissue) around the lesion

Strengths:⁵

• Non-invasive, no radiation
• Excellent soft tissue resolution.
• Detects both symptomatic and asymptomatic lesions
• Can monitor changes over time

Limitations:

• Costly
• Not always available in emergency settings
• Contraindicated (meaning it cannot be used) for patients with certain implants or claustrophobia

Computed tomography (CT)

CT scans are often the first imaging study ordered in emergency situations, especially when a patient presents with sudden headache, seizure or neurological symptoms.⁶ While CT is excellent for detecting acute haemorrhages, it often misses smaller or non-bleeding cavernous malformations.⁶ CT scans, while fast, are limited.

When CT is Useful:

• Detecting haemorrhage
• Quick screening in trauma or acute settings

Shortcomings:⁶

• Poor contrast resolution compared to MRI, meaning various structures in the body cannot be seen as clearly in the image
• Inability to visualise most CMs
• Exposure to ionising radiation (radiation that can potentially cause cell mutation)

In many cases, a suspicious finding on CT will prompt follow-up with MRI to confirm the presence of a CM.

Digital subtraction angiography (DSA)

DSA is ideal for assessing many vascular abnormalities, but not cavernous malformations. Because CMs lack large feeding arteries or venous drainage patterns, they’re almost completely invisible on angiography.⁷

DSA may still be performed in cases where the diagnosis is uncertain, especially if other types of vascular lesions (like arteriovenous malformations or dural fistulas) are in the differential diagnosis.⁷

Takeaway

• Don’t rely on DSA to identify CMs
• It’s more useful to rule out other pathologies

Functional MRI (FMRI) and other functional imaging

In certain cases, before surgical intervention, a functional MRI can be used to map critical brain areas adjacent to a CM. This helps neurosurgeons avoid eloquent brain regions (like those responsible for speech or motor control) during surgery.⁸

Additionally, diffusion tensor imaging (DTI) and tractography are used to visualise white matter tracts.⁸ This can help assess whether a CM is compressing or invading key brain pathways.

These tools don’t diagnose CMs but help plan treatment.⁸

Genetic testing and imaging in familial cases

In familial cavernous malformation syndromes, multiple lesions are common. Here, whole-brain MRIs with SWI are particularly valuable for tracking the emergence of new lesions over time.

Genetic testing isn’t an imaging modality, but it works hand-in-hand with MRI in managing familial cases. Once a genetic mutation is confirmed, family members can be screened with imaging, even if asymptomatic.

Diagnosis to management

While imaging forms the cornerstone of diagnosing cavernous malformations, the patient’s journey doesn’t stop at identification. What follows is often a nuanced process of clinical decision-making that balances risk, lifestyle and long-term neurological health. 

Once a CM is detected (if it’s symptomatic or located in a critical brain region), patients and clinicians must decide whether to observe, intervene or escalate care. This process typically involves a multidisciplinary team: neurologists, radiologists, neurosurgeons and sometimes genetic counsellors or neuropsychologists.^{1, 2}

Asymptomatic patients

A CM is often discovered incidentally. While this can cause some anxiety, many of these lesions remain harmless for life. The standard approach here is watchful waiting: periodic MRIs (usually once a year or every few years) using SWI sequences to monitor for new bleeding, growth or emergence of new lesions. This type of surveillance allows doctors to step in early if the lesion begins to change while avoiding unnecessary intervention in stable cases.¹

Symptomatic cavernous malformations 

Those that cause seizures, neurological deficits or haemorrhage can require a more aggressive approach. Surgery becomes a consideration when the lesion is accessible and causes repeated symptoms.

In these circumstances, advanced imaging tools like functional MRI (fMRI) and diffusion tensor imaging (DTI) are used to create a “functional map” of the brain.⁸ These help neurosurgeons avoid damaging areas responsible for movement, language or vision. Radiosurgery (focused radiation) may be an alternative in select cases, though its use remains more limited and controversial.⁸

Patients with familial cavernous malformation syndromes 

Those with multiple or recurrent lesions present different challenges. Not every lesion needs treatment, but high-risk ones require careful imaging surveillance over time. Genetic testing may lead to screening of asymptomatic family members, allowing early detection and management. 

In this context, imaging becomes a long-term navigational tool that informs how, when, and whether to intervene. Through regular scans and care, clinicians can offer direction, turning a complex diagnosis into a manageable path forward.

Case study

Consider a 35-year-old woman presenting with a seizure and an unremarkable CT scan. Given her symptoms, an MRI with SWI is ordered, revealing three small cavernous malformations, one near the motor cortex. Surgery isn’t needed, but she is monitored with annual MRIs. Later, genetic testing confirms a familial CCM mutation, prompting screening for her siblings.

This case highlights how critical MRI is, not just for diagnosis. It is needed for shaping a patient’s medical journey.

Future directions in imaging

Imaging technology is moving fast. Ultra-high field MRIs offer even sharper resolution, capable of identifying lesions that were previously invisible. These machines are currently more common in research, but clinical use is expanding.⁹

Artificial intelligence is also rising via identification programmes. Algorithms are being trained to identify and classify brain lesions, potentially reducing diagnostic delays or oversights.⁹

Conclusion

Cavernous malformations are elusive, but with the right imaging tools, they don’t stay hidden for long. MRI remains the workhorse (especially with advanced sequences like SWI), but CT provides quick snapshots in emergencies. Other tools like fMRI, DTI and genetic testing play important supporting roles.

For patients, understanding which imaging methods are used and why can reduce anxiety and promote proactive care. For clinicians, it’s a reminder that different imaging modalities are vital for diagnosis in difficult scenarios involving cavernous malformations.

As imaging technology continues to excel, so too does our ability to see clearly what was once obscured, hoping to improve the diagnosis and management of cavernous malformations.